BAMS
IMGN

Bellevue Asset Management (Switzerland)’s Immunogen Inc IMGN Stock Holding History

Bellevue Asset Management (Switzerland)’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$407K Hold
30,000
– – 0.06% 117
2015
Q3 		$288K Buy
+30,000
New +$439K 0.05% 122

Other funds holding IMGN

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return

Bellevue Asset Management (Switzerland)'s IMGN Position: Q4 2015 in Review

Bellevue Asset Management (Switzerland) held its Immunogen Inc (IMGN) position steady in Q4 2015 at 30,000 shares worth $407K. The position accounts for 0.06% of the portfolio, ranked #117.

Bellevue Asset Management (Switzerland) first reported a position in IMGN in Q3 2015 and has held it in 2 quarters since. 152 funds tracked by Wall St. Rank hold IMGN as of Q4 2015.

  • Bellevue Asset Management (Switzerland) held 30,000 shares of Immunogen Inc worth $407K as of Q4 2015.
  • Bellevue Asset Management (Switzerland) left its Immunogen Inc share count unchanged in Q4 2015.
  • Immunogen Inc made up 0.06% of Bellevue Asset Management (Switzerland)'s portfolio in Q4 2015, its #117 holding.
  • Bellevue Asset Management (Switzerland) first reported a position in Immunogen Inc in Q3 2015 and has held it in 2 quarters since.
  • 152 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2015.

Based on Bellevue Asset Management (Switzerland)'s 13F filing for Q4 2015, filed 12 Feb 2016.